Pygeum: Research, Dosing, and Where to Buy in 2026
A research-first profile for Pygeum, aggregating mechanism notes, transcript dosing mentions, vendor recommendations, and PubMed-indexed literature without presenting medical guidance.
Pygeum is a research compound profiled here from named-expert transcripts and peer-reviewed literature, without medical guidance. As of July 2026, The Peptide Wiki aggregates 8 PubMed-cited papers, and 1 attributed expert mention for Pygeum, each linked to its source.
- 0 aggregated dosing-protocol mentions from source transcripts.
- 8 PubMed-indexed citations listed in the research table below.
- 0 vendor recommendations captured from named experts.
- Evidence level in this entry is marked as anecdotal.
What is Pygeum?
Research compound aggregated from creator and literature mentions. No direct disease-treatment claims are made on this page.
What is Pygeum researched for?
Botanical DHT modulator suggested before pharmaceutical 5-AR inhibitors.
Experts on uses and effects · 1 cited mention
"I would look at the pygmium and salt metal first and and and just and check your DHT levels."
Pygeum Dosing Protocols
The entries below are transcript-derived dosing mentions. They are preserved for research context and are not medical advice.
No transcript-derived dosing mentions in current source set.
Where to Buy Pygeum in 2026
No tracked vendor recommendations for Pygeum yet. See our vendor directory.
Side Effects and Safety
Anecdotal reports and study-level observations vary by route, dose, and individual. This page does not provide medical advice. Consult a qualified clinician before any research use.
What Experts Say
1 expert across our source library discuss Pygeum. Each entry is that expert’s most context-rich mention: click to watch it at the exact timestamp in the original video. Quotes are also emitted as Schema.org Quotation JSON-LD for AI assistants.
-
“I would look at the pygmium and salt metal first and and and just and check your DHT levels.”
User Reviews
User reviews aggregator coming Q3 2026 (Reddit + YouTube comments + Discord research notes). Until then, see the expert quote section above and PubMed citations below.
Research Efficacy Snapshot
Published efficacy percentages cited in PubMed trials and named-expert reports about Pygeum. Each line links to the original source.
- "Lower urinary tract symptoms from benign prostatic hyperplasia affect 25% of U.S." · Arnold M et al, 2023 PubMed
- "Only 1% of patients with lower urinary tract symptoms require surgery." · Arnold M et al, 2023 PubMed
- "Hair loss or alopecia is a common dermatological condition affecting up to 2% of the world population." · Gasmi A et al, 2023 PubMed
- "Men using Pygeum africanum were more than twice as likely to report an improvement in overall symptoms (RR=2.1, 95% CI = 1.4, 3.1)." · Wilt T et al, 2002 PubMed
- "Nocturia was reduced by 19%, residual urine volume by 24% and peak urine flow was increased by 23%." · Wilt T et al, 2002 PubMed
- "The overall dropout rate was 12% and was similar between Pygeum Africanum (13%), placebo (11%) and other controls (8%)." · Wilt T et al, 2002 PubMed
- "africanum provided a moderately large improvement in the combined outcome of urologic symptoms and flow measures as assessed by an effect size defined by the difference of the mean change for each outcome divided by the pooled standard deviation for each outcome (-0.8 SD [95% confidence interval (CI): -1.4 to -0.3])." · Ishani A et al, 2000 PubMed
- "Men were more than twice as likely to report an improvement in overall symptoms (risk ratio = 2.1, 95% CI: 1.40 to 3.1)." · Ishani A et al, 2000 PubMed
- "Nocturia was reduced by 19% and residual urine volume by 24%; peak urine flow was increased by 23%." · Ishani A et al, 2000 PubMed
- "The overall dropout rate was 12% and was similar for P." · Ishani A et al, 2000 PubMed
Research and Studies
8 PubMed-indexed papers reference Pygeum. Top 8 shown.
Legal Status
Pygeum is presented here as a research compound. FDA approval status, scheduling, WADA status, and state-specific telehealth rules may apply. Always verify current regulatory status. Last verified: 2026-07-09.
Frequently Asked Questions
Is Pygeum FDA-approved?
Pygeum is presented on this page as a research compound. FDA approval status, scheduling, and state-specific rules may apply and change. Verify current regulatory status before any decision.
How much research has been published on Pygeum?
8 PubMed-indexed paper(s) reference Pygeum in our current research feed. See the Research and Studies section above for citations.